Thomson Reuters

NEW YORK (GenomeWeb) – GenoSpace has received an undisclosed financial investment from Thomson Reuters that it will use to expand its customer base in research, clinical development, laboratory medicine, and clinical care.

This week, Thomson Reuters launched Cortellis Data Fusion, an addition to the company's Cortellis suite, which provides access to information for drug discovery and development.

Because most pure-play bioinformatics companies aren't publicly traded, the sector doesn’t have the financial barometer that things like quarterly earnings reports provide, making it somewhat challenging to gauge growth and speculate about future gains.

Tohoku University's Tohoku Medical Megabank Organization (ToMMo) is using informatics solutions from Thomson Reuters to support a large-scale genome research project aimed at furthering personalized medicine efforts.

Thomson Reuters and NuMedii this week announced a partnership that will pair NuMedii's underlying informatics technology with curated drug and disease information and systems biology expertise from Thomson Reuters for use in identifying new applications for existing drugs.

Last week, Thomson Reuters said that it had purchased Entagen, a privately-owned informatics company that offers semantic search and navigation software and custom development services to pharmaceutical, biotechnology, and laboratory automation companies, for an undisclosed amoun

Certara said this week that it is partnering with Thomson Reuters to provide customers of its D360 software solution with access to content contained in Thomson Reuters' Cortellis for Informatics system.